Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 1,081–1,100 of 18,047 drug recalls

Drug Recall Ongoing Historical recordClass III

Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-905-90

by AvKARE

Reason
Failed Impurity/Degradation Specifications
Recall initiated
June 26, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass III

Pitavastatin Tablets, 1 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiwan, NDC 0480-3631-98.

by Orient Pharma Co., Ltd. Yunlin Plant

Reason
Failed Impurities/Degradation Specifications.
Recall initiated
June 11, 2025
Reported by FDA
July 9, 2025
Distribution
NJ

View recall →

Drug Recall Ongoing Historical recordClass III

Pitavastatin Tablets, 2 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Yunlin, Taiwan, 63247, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054, Product of Taiwan, NDC 0480-3632-98.

by Orient Pharma Co., Ltd. Yunlin Plant

Reason
Failed Impurities/Degradation Specifications.
Recall initiated
June 11, 2025
Reported by FDA
July 9, 2025
Distribution
NJ

View recall →

Drug Recall Ongoing Historical recordClass II

Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70010-780-05; Rx only, Manufactured by: Granules India Limited, Hyderadab-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151,

by Granules Pharmaceuticals Inc.

Reason
Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.
Recall initiated
June 24, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the USA.

View recall →

Drug Recall Ongoing Historical recordClass II

Gabapentin Capsules, USP, 100 mg, 10 capsules (10x1) per bag, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-3363-0

by The Harvard Drug Group LLC

Reason
Defective container; blister packaging inadequately sealed.
Recall initiated
June 19, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61

by The Harvard Drug Group LLC

Reason
Defective container; blister packaging inadequately sealed.
Recall initiated
June 19, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

Orajel Baby, Cooling Swabs for Teething, Each Unit 0.007 fl oz (0.22 mL), NET 0.08 FL OZ (2.6 mL) TOTAL, 12 Single-Use Swabs per carton, Manufactured for Church & Dwight Co. Inc. Ewing. NJ 08328 USA. UPC CODE 3 10310 40000 2.

by Church & Dwight Inc

Reason
Microbial Contamination of Non-Sterile Products: Fungal contamination of infant oral swabs.
Recall initiated
June 6, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the USA.

View recall →

Drug Recall Ongoing Historical recordClass I

ZICAM NASAL ALLCLEAR, 20 Single-Use Swabs per carton, Distributed by Church & Dwight Co,. Inc.., Ewing NJ. UPC 7 32216 30165 6

by Church & Dwight Inc

Reason
Microbial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.
Recall initiated
June 6, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the USA.

View recall →

Drug Recall Ongoing Historical recordClass I

ZICAM COLD REMEDY MEDICATED NASAL SWABS, 20 Single-Use Swabs per carton, Distributed by Church & Dwight Co,. Inc., Ewing NJ. UPC 7 32216 30120 5

by Church & Dwight Inc

Reason
Microbial Contamination of Non-Sterile Products: Fungal contamination of nasal swabs.
Recall initiated
June 6, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the USA.

View recall →

Drug Recall Ongoing Historical recordClass II

LIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative Free, 10mL Sterile Single-Dose Vial, Rx Only, Medivant Healthcare, 158 S. Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0001-0.

by Tailstorm Health INC

Reason
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Recall initiated
June 2, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass II

LIDOcaine HCL Sterile Injection, USP, 100mg/10mL, 1%, (10mg/mL), w/EPINEPHRINE 1:100,000, For Infiltration & Nerve Block, Including Caudal & Epidural Use, 10 mL Sterile Single-Dose Vial, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S. Kyrene, Rd. Chandler, AZ 85226, NDC 81483-0037-0.

by Tailstorm Health INC

Reason
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Recall initiated
June 2, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass II

KETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL Sterile Multi-Dose Vial, Rx Only, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S. Kyrene, Rd. Chandler, AZ 85226, NDC 81483-0007-2.

by Tailstorm Health INC

Reason
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Recall initiated
June 2, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass II

KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.

by Tailstorm Health INC

Reason
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Recall initiated
June 2, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass II

BUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0.5%, (5mg/mL), 10 mL Sterile Single-Dose Vial, Rx Only, For Nerve Block, Caudal & Epidural Anesthesia Only, Warning: Contains Sulfites, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S. Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0036-0.

by Tailstorm Health INC

Reason
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Recall initiated
June 2, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass II

LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, Rx Only, For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative-Free, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0000-0.

by Tailstorm Health INC

Reason
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Recall initiated
June 2, 2025
Reported by FDA
July 9, 2025
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass II

TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01

by Advanced Pharmaceutical Technology, Inc.

Reason
Marketed Without an Approved NDA/ANDA
Recall initiated
May 30, 2025
Reported by FDA
July 2, 2025
Distribution
NY, NJ

View recall →

Drug Recall Ongoing Historical recordClass II

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, 15 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-3

by Apotex Corp.

Reason
Lack of Assurance of Sterility
Recall initiated
May 28, 2025
Reported by FDA
July 2, 2025
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

Azelastine HCl Ophthalmic Solution, USP, 0.05%, 6 mL, Rx Only, Sterile, Mfg. by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0578-4

by Apotex Corp.

Reason
Lack of Assurance of Sterility
Recall initiated
May 28, 2025
Reported by FDA
July 2, 2025
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-2

by Apotex Corp.

Reason
Lack of Assurance of Sterility
Recall initiated
May 28, 2025
Reported by FDA
July 2, 2025
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

0.9% Sodium Chloride Injection USP, 500 mL, packaged in 500 mL excel containers and further packaged 24 per case, Rx only, B.Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC 0264-7800-10.

by B BRAUN MEDICAL INC

Reason
Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
Recall initiated
June 16, 2025
Reported by FDA
July 2, 2025
Distribution
USA Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.